CCDC87
gene geneOn this page
Also known as FLJ10786
Summary
CCDC87 (coiled-coil domain containing 87, HGNC:25579) is a protein-coding gene on chromosome 11q13.2, encoding Coiled-coil domain-containing protein 87 (Q9NVE4). Plays a role in spermatogenesis, where it is important for normal sperm head morphology.
Predicted to be involved in positive regulation of acrosome reaction and positive regulation of fertilization.
Source: NCBI Gene 55231 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 141 total
- MANE Select transcript:
NM_018219
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25579 |
| Approved symbol | CCDC87 |
| Name | coiled-coil domain containing 87 |
| Location | 11q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ10786 |
| Ensembl gene | ENSG00000182791 |
| Ensembl biotype | protein_coding |
| Entrez | 55231 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000333861
RefSeq mRNA: 1 — MANE Select: NM_018219
NM_018219
CCDS: CCDS8145
Canonical transcript exons
ENST00000333861 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001315117 | 66590176 | 66593063 |
Expression profiles
Bgee: expression breadth ubiquitous, 107 present calls, max score 84.14.
FANTOM5 (CAGE): breadth broad, TPM avg 0.8894 / max 61.3476, expressed in 449 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 120817 | 0.7778 | 395 |
| 120818 | 0.1116 | 47 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.14 | gold quality |
| left testis | UBERON:0004533 | 78.29 | gold quality |
| right testis | UBERON:0004534 | 77.80 | gold quality |
| testis | UBERON:0000473 | 76.23 | gold quality |
| triceps brachii | UBERON:0001509 | 65.06 | gold quality |
| adult organism | UBERON:0007023 | 64.93 | gold quality |
| gluteal muscle | UBERON:0002000 | 64.88 | gold quality |
| male germ cell | CL:0000015 | 62.49 | gold quality |
| sperm | CL:0000019 | 62.02 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 61.67 | gold quality |
| secondary oocyte | CL:0000655 | 61.60 | gold quality |
| olfactory bulb | UBERON:0002264 | 61.46 | gold quality |
| type B pancreatic cell | CL:0000169 | 61.33 | gold quality |
| islet of Langerhans | UBERON:0000006 | 60.91 | gold quality |
| quadriceps femoris | UBERON:0001377 | 60.41 | gold quality |
| vastus lateralis | UBERON:0001379 | 59.88 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 57.40 | gold quality |
| pancreatic ductal cell | CL:0002079 | 56.16 | silver quality |
| prefrontal cortex | UBERON:0000451 | 56.02 | gold quality |
| cortical plate | UBERON:0005343 | 54.74 | silver quality |
| myocardium | UBERON:0002349 | 54.55 | gold quality |
| muscle tissue | UBERON:0002385 | 54.11 | silver quality |
| oocyte | CL:0000023 | 53.29 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 53.18 | gold quality |
| deltoid | UBERON:0001476 | 52.69 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 52.31 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 51.90 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 51.86 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 50.09 | silver quality |
| thymus | UBERON:0002370 | 49.94 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.13 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
17 targeting CCDC87, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-6857-5P | 99.87 | 65.32 | 985 |
| HSA-MIR-6079 | 99.84 | 68.54 | 1170 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4708-3P | 99.51 | 67.99 | 870 |
| HSA-MIR-3612 | 99.45 | 66.02 | 1333 |
| HSA-MIR-650 | 99.45 | 65.77 | 1309 |
| HSA-MIR-6828-5P | 99.31 | 69.21 | 1433 |
| HSA-MIR-3190-5P | 98.87 | 64.89 | 1345 |
| HSA-MIR-4450 | 98.26 | 68.35 | 725 |
| HSA-MIR-1226-5P | 96.50 | 65.28 | 643 |
| HSA-MIR-6782-5P | 96.45 | 64.42 | 612 |
| HSA-MIR-601 | 95.98 | 67.59 | 421 |
| HSA-MIR-6888-5P | 95.89 | 63.78 | 831 |
| HSA-MIR-4474-5P | 94.23 | 67.95 | 568 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ccdc87 | ENSDARG00000045683 |
| mus_musculus | Ccdc87 | ENSMUSG00000067872 |
| rattus_norvegicus | Ccdc87 | ENSRNOG00000071751 |
Protein
Protein identifiers
Coiled-coil domain-containing protein 87 — Q9NVE4 (reviewed: Q9NVE4)
All UniProt accessions (1): Q9NVE4
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in spermatogenesis, where it is important for normal sperm head morphology. Also required for the acrosome reaction and thus normal male fertility.
Similarity. Belongs to the CCDC87 family.
RefSeq proteins (1): NP_060689* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR037383 | CCDC87 | Family |
Pfam: PF03999
UniProt features (6 total): sequence variant 2, sequence conflict 2, chain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NVE4-F1 | 62.53 | 0.09 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 58 (showing top):
GOBP_SINGLE_FERTILIZATION, GOBP_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS, GOBP_MALE_GAMETE_GENERATION, chr11q13, GOBP_REGULATION_OF_REPRODUCTIVE_PROCESS, GOBP_REGULATION_OF_ACROSOME_REACTION, GOBP_ACROSOME_REACTION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON, GOBP_FERTILIZATION, YGCGYRCGC_UNKNOWN, HATADA_METHYLATED_IN_LUNG_CANCER_UP, WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR, WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D, GOBP_REGULATION_OF_FERTILIZATION
GO Biological Process (5): spermatogenesis (GO:0007283), single fertilization (GO:0007338), cell differentiation (GO:0030154), positive regulation of fertilization (GO:1905516), positive regulation of acrosome reaction (GO:2000344)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| fertilization | 2 |
| positive regulation of reproductive process | 2 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| regulation of fertilization | 1 |
| acrosome reaction | 1 |
| regulation of acrosome reaction | 1 |
| binding | 1 |
Protein interactions and networks
STRING
182 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC87 | DCDC2B | A2VCK2 | 561 |
| CCDC87 | MIX23 | Q4VC31 | 513 |
| CCDC87 | CCDC97 | Q96F63 | 479 |
| CCDC87 | PRR14L | Q5THK1 | 477 |
| CCDC87 | FAM184B | Q9ULE4 | 451 |
| CCDC87 | ARHGAP6 | O43182 | 365 |
| CCDC87 | UBR4 | Q5T4S7 | 361 |
| CCDC87 | MIPEP | Q99797 | 344 |
| CCDC87 | ZNF451 | Q9Y4E5 | 337 |
| CCDC87 | ANO5 | Q75V66 | 324 |
| CCDC87 | ZNF329 | Q86UD4 | 305 |
| CCDC87 | MTCL1 | Q9Y4B5 | 301 |
| CCDC87 | PDE1C | Q14123 | 282 |
| CCDC87 | ZNF592 | Q92610 | 262 |
| CCDC87 | SUN2 | Q9UH99 | 251 |
IntAct
30 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GOLGA2 | CCDC87 | psi-mi:“MI:0915”(physical association) | 0.720 |
| SUN2 | LMNA | psi-mi:“MI:0914”(association) | 0.720 |
| TRIM27 | CCDC87 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC87 | KRT15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| USHBP1 | CCDC87 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM54 | CCDC87 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC87 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC87 | TRIM27 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC87 | TRIM54 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDR2 | CCDC87 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC87 | STAT3 | psi-mi:“MI:0915”(physical association) | 0.490 |
| STAT3 | CCDC87 | psi-mi:“MI:0915”(physical association) | 0.490 |
| YAP1 | CCDC87 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| CCDC87 | KASH5 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SUN2 | MYO1C | psi-mi:“MI:0914”(association) | 0.350 |
| MKI67 | ARHGAP10 | psi-mi:“MI:0914”(association) | 0.350 |
| ESR2 | PSMD11 | psi-mi:“MI:0914”(association) | 0.350 |
| CCDC87 | GOLGA2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CCDC87 | CDR2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (23): CCDC87 (Two-hybrid), CCDC87 (Two-hybrid), CCDC87 (Two-hybrid), TRIM54 (Two-hybrid), USHBP1 (Two-hybrid), CCDC155 (Two-hybrid), CCDC87 (Two-hybrid), CCDC87 (Affinity Capture-MS), CCDC87 (Affinity Capture-MS), CCDC87 (Affinity Capture-RNA), CCDC87 (Two-hybrid), CCDC87 (Two-hybrid), CCDC87 (Affinity Capture-MS), CCDC87 (Affinity Capture-MS), CCDC87 (Protein-peptide)
ESM2 similar proteins: A0JNF3, A1L253, A2AHC3, A3KP40, A5PLN7, A5WUN7, A6H5Y1, B1AXH1, B2GUZ2, D3Z8E6, E9PV87, E9Q309, H6D7E6, O14513, O60303, P0CAX8, P28290, Q14B48, Q1G7G9, Q2KHM9, Q32LN6, Q49A88, Q566N9, Q5HYW2, Q5PQL8, Q5REU9, Q5T5Y3, Q5VT06, Q60664, Q66H35, Q66MI6, Q6A000, Q6AYP4, Q6NSV7, Q6NXP0, Q6ZRS4, Q6ZVD7, Q80VP2, Q8BJS7, Q8CB14
Diamond homologs: Q8CDL9, Q9NVE4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
141 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 131 |
| Likely benign | 10 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
97 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:66592872:G:T | donor_gain | 0.9900 |
| 11:66593041:G:GT | donor_gain | 0.9900 |
| 11:66592872:G:GT | donor_gain | 0.9700 |
| 11:66593042:A:T | donor_gain | 0.9700 |
| 11:66593058:GTTAC:G | donor_gain | 0.9700 |
| 11:66593059:TTACT:T | donor_gain | 0.9700 |
| 11:66593056:GGGT:G | donor_gain | 0.9300 |
| 11:66592941:G:GT | donor_gain | 0.9100 |
| 11:66593047:A:T | donor_gain | 0.8900 |
| 11:66592941:G:T | donor_gain | 0.8800 |
| 11:66592924:G:T | donor_gain | 0.8700 |
| 11:66592969:T:TA | donor_gain | 0.8700 |
| 11:66592970:G:GA | donor_gain | 0.8700 |
| 11:66592876:G:GT | donor_gain | 0.8600 |
| 11:66592971:G:GG | donor_gain | 0.8600 |
| 11:66593062:C:G | donor_gain | 0.8500 |
| 11:66592968:G:GT | donor_gain | 0.8100 |
| 11:66592924:G:GT | donor_gain | 0.8000 |
| 11:66592992:C:T | donor_gain | 0.8000 |
| 11:66592968:GTG:G | donor_gain | 0.7900 |
| 11:66592986:C:G | donor_gain | 0.7400 |
| 11:66592967:GGTG:G | donor_gain | 0.7300 |
| 11:66592955:G:GT | donor_gain | 0.7100 |
| 11:66592964:GCCG:G | donor_gain | 0.7000 |
| 11:66592873:A:T | donor_gain | 0.6600 |
| 11:66592966:C:A | donor_gain | 0.6600 |
| 11:66592963:AGCC:A | donor_gain | 0.5700 |
| 11:66593062:C:CG | donor_gain | 0.5600 |
| 11:66592991:GC:G | donor_gain | 0.5200 |
| 11:66592966:CGGTG:C | donor_loss | 0.5100 |
AlphaMissense
5512 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:66592644:G:C | S124R | 0.987 |
| 11:66592644:G:T | S124R | 0.987 |
| 11:66592646:T:G | S124R | 0.987 |
| 11:66592733:A:G | W95R | 0.986 |
| 11:66592733:A:T | W95R | 0.986 |
| 11:66592530:G:C | C162W | 0.985 |
| 11:66592314:G:C | S234R | 0.984 |
| 11:66592314:G:T | S234R | 0.984 |
| 11:66592316:T:G | S234R | 0.984 |
| 11:66592744:A:G | L91P | 0.984 |
| 11:66592636:A:G | L127P | 0.981 |
| 11:66592647:G:C | S123R | 0.981 |
| 11:66592647:G:T | S123R | 0.981 |
| 11:66592649:T:G | S123R | 0.981 |
| 11:66592681:A:G | L112P | 0.980 |
| 11:66592672:C:G | R115P | 0.979 |
| 11:66592543:A:G | L158P | 0.977 |
| 11:66592532:A:G | C162R | 0.975 |
| 11:66592492:A:G | L175P | 0.971 |
| 11:66592731:C:A | W95C | 0.969 |
| 11:66592731:C:G | W95C | 0.969 |
| 11:66592519:A:G | L166P | 0.967 |
| 11:66592531:C:T | C162Y | 0.967 |
| 11:66592678:C:G | R113P | 0.966 |
| 11:66592669:A:G | L116P | 0.964 |
| 11:66591177:A:C | F613L | 0.963 |
| 11:66591177:A:T | F613L | 0.963 |
| 11:66591179:A:G | F613L | 0.963 |
| 11:66591192:G:C | F608L | 0.962 |
| 11:66591192:G:T | F608L | 0.962 |
dbSNP variants (sampled 300 via entrez): RS1000727023 (11:66594179 A>G), RS1001942552 (11:66594791 A>C,T), RS1002857887 (11:66592715 C>A,G,T), RS1003140973 (11:66592929 C>A), RS1003191553 (11:66593926 T>C), RS1003473448 (11:66594225 G>C), RS1003701432 (11:66589861 G>C), RS1003732738 (11:66589681 C>A,T), RS1005670519 (11:66589711 C>A), RS1005707688 (11:66594299 C>T), RS1006371587 (11:66594803 C>T), RS1007572179 (11:66594965 A>C), RS1007614575 (11:66590396 T>A), RS1008372278 (11:66591962 T>A,C), RS1010244995 (11:66594220 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001241_12 | Bipolar disorder | 2.000000e-07 |
| GCST007576_250 | Chronotype | 5.000000e-13 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008328 | chronotype measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| (+)-JQ1 compound | increases expression | 2 |
| Benzo(a)pyrene | increases methylation, affects methylation, increases expression | 2 |
| sotorasib | affects cotreatment, increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| trametinib | increases expression, affects cotreatment | 1 |
| NVP-BKM120 | increases expression, affects cotreatment | 1 |
| Sunitinib | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.